Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (26)

« Back to Publications

Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.

Bendardaf R. et al, (2008), Oncol Rep, 20, 999 - 1004

Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.

Bendardaf R. et al, (2008), Acta Oncol, 47, 1046 - 1053

Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.

Bendardaf R. et al, (2007), Scand J Gastroenterol, 42, 471 - 476

Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.

Bendardaf R. et al, (2007), Tumour Biol, 28, 212 - 220

Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.

Bendardaf R. et al, (2006), Oncol Rep, 16, 741 - 746

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.

Elzagheid A. et al, (2006), World J Gastroenterol, 12, 4304 - 4309

Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer.

Bendardaf R. et al, (2005), Oncol Rep, 14, 657 - 662

E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer.

Bendardaf R. et al, (2005), Oncol Rep, 13, 831 - 835

Nuclear area is a prognostic determinant in advanced colorectal cancer.

Buhmeida A. et al, (2005), Anticancer Res, 25, 3083 - 3088

Prognostic and predictive molecular markers in colorectal carcinoma.

Bendardaf R. et al, (2004), Anticancer Res, 24, 2519 - 2530

Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content.

Bendardaf R. et al, (2004), Oncology, 66, 46 - 52

CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.

Bendardaf R. et al, (2004), Oncol Rep, 11, 41 - 45

Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.

Crabtree M. et al, (2003), Oncogene, 22, 4257 - 4265

poptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma.

Bendardaf R. et al, (2003), Oncology, 64, 435 - 442

Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma.

Bendardaf R. et al, (2003), Oncology, 65, 337 - 346

Load More